Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
June 14, 2007
SANOFI-AVENTIS U.S. LLC et al v. SANDOZ, INC.
Case Number:
3:07-cv-02762
Court:
Nature of Suit:
Judge:
Firms
- Cole Schotz
- Eckert Seamans
- Faegre Drinker
- Flaster Greenberg
- Fox Rothschild
- Greenbaum Rowe
- Hill Wallack
- Kozyra & Hartz
- Lite DePalma
- McCarter & English
- Patunas Law
- Porzio Bromberg
- Quinn Emanuel
- Rivkin Radler
- Robinson Miller
- Saiber LLC
- Saul Ewing
- Weil Gotshal
- Wiley Malehorn
Companies
- Abraxis BioScience Inc.
- Allergan PLC
- Fresenius Kabi AG
- Hospira Inc.
- Par Pharmaceutical Cos. Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 16, 2011
Sun Can't Sell Generic Eloxatin Until 2012: Judge
Sun Pharmaceutical Industries Ltd. can't market its generic version of Sanofi-Aventis SA's colorectal cancer treatment Eloxatin until August 2012, based on the terms of a licensing agreement between the companies, a New Jersey federal judge said Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login